American Tower to Present at the J.P. Morgan Global Technology, Media and Communications Conference
BOSTON--(BUSINESS WIRE)--American Tower Corporation (NYSE: AMT) today announced that it is scheduled to present at the 53rd Annual J.P. Morgan Global Technology, Media and Communications Conference on Tuesday, May 13, 2025 at 10:50 a.m. ET in Boston, Massachusetts.
A live webcast and replay of the presentation will be accessible from the Investor Relations section of American Tower's website at www.americantower.com/investor-relations.
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 149,000 communications sites and a highly interconnected footprint of U.S. data center facilities. For more information about American Tower, please visit www.americantower.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
an hour ago
- Forbes
Buy Or Fear Oil-Dri Of America Stock
Oil-Dri of America (NYSE:ODC) stock appears appealing – making it a wise choice for purchase at its present price of approximately $55. We have identified some minor issues with ODC stock, which makes it enticing given that its current valuation seems low. Our conclusion is drawn from comparing the current valuation of ODC stock to its operational performance in recent years, as well as its current and historical financial state. Our analysis of Oil-Dri of America across key parameters of Growth, Profitability, Financial Stability, and Downturn Resilience indicates that the company exhibits a robust operating performance and financial status, as clarified below. However, for those investors who prefer lower volatility than individual stocks, the Trefis High Quality Portfolio offers an alternative – having outperformed the S&P 500 and yielded returns surpassing 91% since its inception. In terms of what you pay for each dollar of sales or profit, ODC stock appears somewhat inexpensive when compared to the wider market. • Oil-Dri of America has a price-to-sales (P/S) ratio of 1.5 compared to a figure of 3.0 for the S&P 500 • Additionally, the company's price-to-free cash flow (P/FCF) ratio stands at 9.5 in contrast to 20.5 for the S&P 500 • Furthermore, it holds a price-to-earnings (P/E) ratio of 15.5 compared to the benchmark's 26.4 Oil-Dri of America's Revenues have experienced significant growth in recent years. • Oil-Dri of America has witnessed its top line increase at an average rate of 12.9% over the past 3 years (versus an increase of 5.5% for the S&P 500) • Its revenues have risen 8.2% from $430 million to $465 million in the last 12 months (compared to growth of 5.5% for the S&P 500) • Additionally, its quarterly revenues increased 10.6% to $117 million in the latest quarter from $106 million a year prior (versus a 4.8% rise for the S&P 500) Oil-Dri of America's profit margins are less favorable than those of most companies in the Trefis coverage universe. • Oil-Dri of America's Operating Income over the previous four quarters totaled $62 million, reflecting a moderate Operating Margin of 13.3% (versus 13.2% for the S&P 500) • Oil-Dri of America's Operating Cash Flow (OCF) during this period was $75 million, indicating a moderate OCF Margin of 16.1% (compared to 14.9% for the S&P 500) • For the last four-quarter period, Oil-Dri of America's Net Income was $46 million – suggesting a poor Net Income Margin of 9.8% (relative to 11.6% for the S&P 500) Oil-Dri of America's balance sheet appears solid. • Oil-Dri of America's Debt was reported at $58 million at the conclusion of the most recent quarter, with its market capitalization standing at $762 million (as of 6/6/2025). This creates a strong Debt-to-Equity Ratio of 8.3% (in contrast to 19.9% for the S&P 500). [Note: A low Debt-to-Equity Ratio is preferable] • Cash (along with cash equivalents) comprises $23 million of the $354 million in Total Assets for Oil-Dri of America. This leads to a moderate Cash-to-Assets Ratio of 6.4% (compared to 13.8% for the S&P 500) ODC stock has experienced a slightly better impact than the benchmark S&P 500 index during certain recent downturns. While investors remain optimistic about a soft landing for the U.S. economy, what might the consequences be if another recession occurs? Our dashboard How Low Can Stocks Go During A Market Crash illustrates how key stocks performed during and after the last six market crashes. • ODC stock dropped 41.5% from a peak of $19.23 on 11 March 2021 to $11.24 on 11 October 2022, compared to a peak-to-trough decline of 25.4% for the S&P 500 • The stock completely recovered to its pre-Crisis peak by 9 March 2023 • Since then, the stock has risen to a high of $54.82 on 8 June 2025 • ODC stock decreased 24.6% from a high of $19.19 on 16 January 2020 to $14.46 on 16 March 2020, compared to a peak-to-trough decline of 33.9% for the S&P 500 • The stock fully recovered to its pre-Crisis peak by 11 March 2021 • ODC stock declined 49.4% from a high of $11.47 on 10 December 2007 to $5.81 on 10 October 2008, in contrast to a peak-to-trough decline of 56.8% for the S&P 500 • The stock fully recovered to its pre-Crisis peak by 17 June 2010 In conclusion, Oil-Dri of America's performance across the parameters outlined above is as follows: • Growth: Very Strong • Profitability: Weak • Financial Stability: Strong • Downturn Resilience: Neutral • Overall: Neutral When considered alongside its low valuation, this renders the stock appealing, supporting our assessment that ODC represents a wise stock to purchase. Although ODC stock appears promising, investing in a single stock bears its risks. Conversely, the Trefis High Quality (HQ) Portfolio, which consists of 30 stocks, has a proven track record of comfortably outperforming the S&P 500 over the past 4 years. What accounts for this? As a collective, HQ Portfolio stocks have delivered superior returns with reduced risk compared to the benchmark index; providing a smoother experience as demonstrated in HQ Portfolio performance metrics.
Yahoo
2 hours ago
- Yahoo
United Healthcare: Earnings, A $200 Billion Overreaction
One of the most dramatic reactions from the Q1 2025 earnings season came from United Healthcare (NYSE:UNH), which shed over $200 billion in market cap and cratered 23% intra-day post-earnings along with continued decline upon the resignation of its CEO and a potential DOJ inquiry. At first glance, that kind of move suggests something catastrophic although the actual results paint a very different picture. Warning! GuruFocus has detected 4 Warning Sign with UNH. The selloff was driven by a 2% increase in Medicare Advantage costs and higher utilization trends (greater related medical expenses), which led to a reduction in 2025 earnings guidance from $29 to $26 per share initially and later with guidance lifted. That's collectively a $3 hit to EPS which is material from initial guidance, but not earth-shattering especially considering UNH is stil projected to have 20.65 billion in 2024 full year net income based on revisions of major investment banks aggregated by Refinitiv along with 25-30 billion for FY26. That level of profit implies a P/E of roughly 12 and a forward P/E of less than 10 (representing a forward cash flow yield of 10%, a truly absurd financial metric for a company of this size), which is deeply discounted for a business of this scale, profitability, and consistency. The increase in utilization is also expected within the earnings call to normalize to historical averages in the near future and this isn't the first time a Medicare Advantage utilization has caused the share price to decline. In June 2023 a similar utilization increase was seen and the effects were short lived, negligible to profitability and the share price quickly was achieving new highs just a six weeks later. Given how the insurance operation works, premiums can also be raised to offset additional care expenses encountered to maintain similar margins and levels of profitability. The CEO also stepped down due to stated personal reasons, while for investors having a CEO step down is typically seen as something negative, the successor for the position is the long term prior CEO Steven J Hemsley, an executive that oversaw exceptional increases in financial operations, efficiency, and stewardship of the company through industry opportunities. While the stock declined rather significantly upon his appointment, this would seem to be dramatic given the prior CEO executed incredible shareholder returns and growth of operations. The last contributor to major negative sentiment is the "announcement/accusation" by journalists a DOJ probe into medicare advantage billing escalating from civil to criminal (uncorroborated by the DOJ or any legal agency), the company explicitly denied any knowledge or informational requests related to such a probe or its supposed existence and given a prior legal ruling in the civil case that there was no apparent incorrect coding for billing, the legitimacy of this seems to be in question. While if the probe is found to be legitimate in the future, as incredible as it sounds, the company would also likely not have any difficulty financing a fine/outlay of significant size. UNH generates profits from a few large business segments albeit diversified due to the massive scale, the insurance operation in which premiums are received and invested/used to pay out claims respectfully and represents the largest health insurer in the US. The other major component of business operations is Optum, which consists of its pharmacy benefit manager operations, Optum Health which directs healthcare directly, and Optum Insights which provides data analytics and consulting. The hit to guidance was within the legacy insurance segment, which remains wildly profitable although the real driver of earnings growth (a greater than 50% share of net income) is seen within Optum which would seem to be unaffected. UNH's capital allocation strategy has historically been a masterclass in shareholder returns. The company has averaged 2-4 billion in quarterly stock buybacks, while simultaneously paying out close to $8 billion in annual dividends all without compromising operations or balance sheet strength. The most recent buyback spike in Q4 2024 was nearly $5 billion, the largest in the past three years. Based on the outlandish profitability of UNH and the businesses clear willingness and ability to reward shareholders, once you throw in the fact that there is a significant discount being placed on the business by the market, it becomes clear this is a sizable overreaction and not reflective of the operations or strength of the company. *historically repurchases accelerate for UNH under market declines This level of profitability and shareholder alignment is rare, and it's even more compelling now that the market has mispriced the stock on short-term guidance noise. The biggest opportunities in investing often come when price temporarily detaches from financial reality and that's exactly what this looks like. With the regime of a current market built on fear and facing macroeconomic struggles, health insurance is generally considered a defensive, non-cyclical industry because demand for healthcare remains relatively stable regardless of economic conditions. People don't stop needing medical care during a recession and if anything, economic stress can drive higher Medicaid enrollment or subsidized marketplace coverage. For insurers like UNH, revenue is largely tied to premiums and government reimbursements, which are contractual or regulated and don't fluctuate with consumer sentiment or discretionary spending trends. Even during downturns, enrollment can remain stable or even grow as individuals shift from employer-sponsored plans to government-backed options. Unlike cyclical sectors like consumer discretionary or industrials, healthcare spending is inelastic and people prioritize it no matter what. Moreover, Medicare Advantage and Medicaid, which are a large part of UNH's book, are government-funded and relatively insulated from short-term economic cycles. As for the broader industry landscape, there are no meaningful moves underway to undercut or dismantle the private health insurance model. The regulatory outlook remains stable, and there are no current legislative pressures that would structurally alter the business model of companies like UNH. Importantly, this volatility in premiums is limited to the UnitedHealthcare segment. Optum UNH's faster-growing, higher margin division which continues to deliver strong performance across health services, pharmacy benefits, and data analytics. Together, this structure gives UNH a diversified revenue model that can weather temporary shocks in one segment without compromising overall earnings power and represents a significantly undervalued equity at current market prices. * TipRanks. (n.d.). UnitedHealth (NYSE:UNH) stock buybacks. Retrieved May 3, 2025, from This article first appeared on GuruFocus.
Business Wire
2 hours ago
- Business Wire
KBRA Releases Global ABS 2025: Day 1 Recap
LONDON--(BUSINESS WIRE)--The Global ABS 2025 conference, held in Barcelona on 10-12 June, opened to a record 5,000+ registered attendees, including over 2,000 issuers and investors, as well as a full programme. The conference celebrated its 29th anniversary as the largest annual European structured finance conference and is hosted by the Association for Financial Markets in Europe (AFME). This year marks the first time the event is being organised by FT Live, following its takeover of the previous organiser, Invisso. Judging by the strong attendance and KBRA's very active meeting calendar, the industry event reflects the growth momentum experienced by European securitisation markets. New transaction issuance started the year on a strong note and, despite a temporary pause, continued to build a robust and positive pipeline of transactions across all product types. Day 1 panels featured market updates on asset-backed securities (ABS), collateralised loan obligations (CLO), commercial mortgage-backed securities (CMBS), nonperforming loans (NPL), and more. Other discussions included broader topics such as regulation and synthetic risk transfer (SRT) securities, including several plenary sessions. KBRA speakers featured on a number of important panels covering solar panel loans, CLOs, and residential mortgage-backed securities (RMBS) markets. Click here to view a recap of some of the day's panel discussions. Recent Publications About KBRA KBRA, one of the major credit rating agencies, is registered in the U.S., EU, and the UK. KBRA is recognized as a Qualified Rating Agency in Taiwan, and is also a Designated Rating Organization for structured finance ratings in Canada. As a full-service credit rating agency, investors can use KBRA ratings for regulatory capital purposes in multiple jurisdictions. Doc ID: 1009819
